Ex parte MCCAFFREY et al. - Page 2




              Appeal No. 94-4393                                                                                          
              Application 07/692,921                                                                                      


                                            REMAND TO THE EXAMINER                                                        
                     We remand this application for the examiner to consider the following issues and                     
              take appropriate action.                                                                                    


                                                Representative Claims                                                     
                     Claims 1, 4, 7, and 9 are illustrative of the subject matter under review in this appeal             
              and read as follows:                                                                                        
                     1.     A method for depleting heparin of a heparin subspecies with high or low                       
              affinity for transforming growth factor-beta which comprises:                                               
                     providing a polypeptide containing a heparin-binding region of TGF-$;                                
                     immobilizing the polypeptide on an insoluble substrate;                                              
                     contacting the immobilized polypeptide with heparin for a sufficient time to allow                   
              binding; and                                                                                                
                     collecting the unbound heparin.                                                                      

                     4.     A method according to Claim 1 which further comprises purifying the                           
              unbound heparin.                                                                                            

                     7.     A purified Heparin subspecies having anticoagulant activity and which does                    
              not bind to transforming growth factor $.                                                                   

                     9.     A method for purifying heparin fractions with high or low affinity for                        
              transforming growth factor-beta which comprises:                                                            


                                                            2                                                             





Page:  Previous  1  2  3  4  5  6  7  8  9  Next 

Last modified: November 3, 2007